RecallRadar

FDA Drug recall D-0605-2017

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Ma…

On 2017-03-29 the FDA classified a Class II recall of ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Ma… by Zydus Pharmaceuticals Usa, citing presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0605-2017
ClassificationClass II
Statusterminated
Initiated2017-03-06
Published2017-03-29
Last updated2026-09-13 11:51 UTC
CompanyZydus Pharmaceuticals Usa
DistributionUS

Product

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Reason

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Identifiers

ndc68382-022-16
ndc68382-022-01
ndc68382-022-10
ndc68382-022-40
ndc68382-022-24
ndc68382-023-16
ndc68382-023-01
ndc68382-023-10
ndc68382-023-02
ndc68382-023-40
ndc68382-023-24
ndc68382-024-16
ndc68382-024-01
ndc68382-024-10
ndc68382-024-40
code_infoLot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0605-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.